Back to search

Canada· CA-DIN-01935941

HEPARIN SODIUM IN 5% DEXTROSE INJECTION, 25000UNIT/500ML

A heparin, kombinationen product containing dextrose + citric acid + heparin sodium + sodium phosphate dibasic, registered in Canada by B. BRAUN MEDICAL INC. The same ATC class is registered in 3 of our 19 countries.

ATC B01AB51

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedHEPARIN SODIUM IN 5% DEXTROSE INJECTI…ATCB01AB51REGISTER NO.CA-DIN-01935941PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Heparin, kombinationen is registered in 3 of 19 countries.

Countries holding a registration under ATC B01AB51 (heparin, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 2 of them publish a price we can compare per daily dose

Heparin, kombinationen · ATC B01AB51

3 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
DEXTROSE + CITRIC ACID + HEPARIN SODIUM + SODIUM PHOSPHATE DIBASIC
Manufacturer
B. BRAUN MEDICAL INC
Country
Canada (CA)
ATC code
B01AB51
ATC class
Heparin, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c1fa7bdc-6a3e-4890-8c3b-78e9ff501f75
GET /v1/drugs/c1fa7bdc-6a3e-4890-8c3b-78e9ff501f75?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "01935941",
  "form": "SOLUTION",
  "class": "Human",
  "routes": [
    "INTRAVENOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "B01AB51",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "16794",
  "strengths": [
    "5 G",
    "93 MG",
    "5000 UNIT",
    "410 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "DEXTROSE",
    "CITRIC ACID",
    "HEPARIN SODIUM",
    "SODIUM PHOSPHATE DIBASIC"
  ],
  "product_categorization": null
}

See everything about heparin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.